Dealmaker Interviews

The panel will discuss in- and out-of-court transactional alternatives available to distressed companies, value maximization leading to the sale, transaction structures, buyer due diligence and deal financing. This program is sponsored by ShareVault ShareVault is the innovation...

WATCH ON DEMAND David Kupetz, a partner at Locke Lord, a leading restructuring and bankruptcy lawyer, and Alex Kasdan, restructuring investment banker and host of Expert Webcast, discuss the fundamentals of Assignments for the Benefit of Creditors (ABC) as an out-of-court...

M&A activity is still significantly above pre-pandemic levels, with healthcare remaining one of the most active industries transactionally. The panel will discuss M&A trends by healthcare verticals, labor and supply chain shortages, financing availability, valuations and...

The panel will discuss cross-border M&A trends in the face of current geopolitical and financial turbulence, including the after-effects of the Pandemic, Russia-Ukraine war, and China’s economic threat. We will address transactional opportunities and structures, due diligence...

Healthcare industry’s post-pandemic resilience and scale continue to attract capital and drive consolidation.  The panel will discuss transactional drivers and headwinds, such as supply chain disruptions and increasing labor costs, financing challenges, systemic distress and...

LEADING FIRMS SHARE KNOWLEDGE ON EXPERT WEBCAST

With the disruptions of the pandemic largely behind us, multinationals and private equity investors are targeting Latin America company acquisitions to leverage natural resource availability, lower labor costs and expanding consumer market demand. The panel will discuss current...

The panel will focus on current regulatory and compliance issues in the Cannabis industry domestically and internationally and their effect on corporate valuations, due diligence, capital investment activity and mergers and acquisitions. Speakers will also address industry...

The panel will discuss transactional activity in various healthcare verticals, deal drivers and challenges, technology and competitive pressures, deal structures and capital availability, and opportunities for private equity investors in the time of uncertainty. We will also...

WATCH THE REPLAY The COVID-19 pandemic has not slowed the dealmaking.  On the contrary, 2021 turned out to be a record year in terms of M&A volume, with $5.9 trillion in deals.  Yet, the deal process and due diligence practices were greatly impacted by the “New Normal.” The...